The effects of hyperglycaemia on thrombin-activatable fibrinolysis inhibitor von VERKLEIJ, Chantal J. N, NIEUWDORP, Max, GERDES, Victor E. A, MÖRGELIN, Matthias, MEIJERS, Joost C. M, MARX, Pauline F

Volltext

Thrombin-activatable fibrinolysis inhibitor in hypothyroidism and hyperthyroxinaemia von Verkleij, Chantal J. N., Stuijver, Danka J. F., van Zaane, Bregje, Squizzato, Alessandro, Brandjes, Dees P. M., Büller, Harry R., Meijers, Joost C. M., Gerdes, Victor E. A.

Volltext

The role of thrombin-activatable fibrinolysis inhibitor in diabetic wound healing von Verkleij, Chantal J.N, Roelofs, Joris J.T.H, Havik, Stefan R, Meijers, Joost C.M, Marx, Pauline F

Volltext

The Hemostatic System in Patients With Type 2 Diabetes With and Without Cardiovascular Disease von Verkleij, Chantal J. N., Bruijn, Roderick E. de, Meesters, Eelco W., Gerdes, Victor E.A., Meijers, Joost C. M., Marx, Pauline F.

Volltext